Axamozide

Axamozide

SCHEMBL11022863

O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CC2COc3ccccc3O2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.60
CHRM1 P11229 3/20 0.59
HTR1A P08908 3/20 0.58
DRD2 P14416 3/20 0.58
HTR2A P28223 3/20 0.58
ADRA2A P08913 2/20 0.58
SLC6A4 P31645 2/20 0.58
DRD3 P35462 2/20 0.58
HTR2C P28335 2/20 0.56
HTR2B P41595 2/20 0.56
MEN1 O00255 1/20 0.56
SLC22A2 O15244 1/20 0.56
NR1I2 O75469 1/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
CYP1A2 P05177 1/20 0.56
GLA P06280 1/20 0.56
ADRB2 P07550 1/20 0.56
ADRB1 P08588 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Axamozide SCHEMBL11027857 0.99 OPRM1 (0.59) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11025222 0.93 HTR1A (0.59) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11100748 0.93 OPRM1 (0.60) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11023441 0.91 DRD3 (0.58) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11098294 0.90 OPRM1 (0.62) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11027738 0.90 HTR1A (0.60) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11096216 0.90 OPRM1 (0.57) OPRM1HTR1ADRD2HTR2AHTR2C
SCHEMBL11093124 0.89 OPRM1 (0.58) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11024054 0.89 DRD2 (0.55) OPRM1CHRM1HTR1ADRD2HTR2A
SCHEMBL11024904 0.89 HTR1A (0.57) OPRM1CHRM1HTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 US disclosed
EP-0068261-B1 N-OXACYCLYL-ALKYLPIPERIDINE DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1985-04-03 EP disclosed